Oruka Therapeutics, Inc. ORKA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s investing cash flow?
- Oruka Therapeutics, Inc. (ORKA) reported investing cash flow of -$14.44M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Oruka Therapeutics, Inc.'s investing cash flow decreased by 133.7% year-over-year, from $42.87M to -$14.44M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s investing cash flow?
- Over 2 years (2021 to 2025), Oruka Therapeutics, Inc.'s investing cash flow has grown at a 4643.3% compound annual growth rate (CAGR), from -$43K to -$96.75M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.